A clinical case of successful application of a new treatment method for severe COVID-19

COVID-19, formerly coronavirus infection 2019-nCoV, is a potentially severe acute respiratory infection caused by the SARS-CoV-2 coronavirus (2019-nCoV). It is a dangerous disease that can occur both in the form of a mild acute respiratory viral infection and in a severe form with the development of bilateral polysegmental viral pneumonia, specific complications of which may include acute respiratory distress syndrome, resulting in the respiratory failure with a high risk of death. Due to the absence of etiotropic therapy for the coronavirus infection, pathogentic treatment becomes of primary importance. We present a clinical case of a severe form of COVID-19 in a 33-year-old man to whom we administered a new method of pathogenetic treatment of this disease based on immunosuppresiive therapy followed by therapeutic plasma exchange and infusion of non-specific human immunoglobulin..

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Клиническая практика - 11(2020), 2, Seite 93-100

Sprache:

Russisch

Beteiligte Personen:

Alexander S. Samoylov [VerfasserIn]
Yuri D. Udalov [VerfasserIn]
Nikolai M. Kruglyakov [VerfasserIn]
Dmitry А. Terekhov [VerfasserIn]
German I. Bagzhanov [VerfasserIn]
Sergey S. Ochkin [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
journals.eco-vector.com [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Case report
Covid-19
Immunosuppression
Medicine
Plasma exchange
R
Selective plasma filtration

doi:

10.17816/clinpract34529

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ064025470